Delivery Order SPE2DB24D3013-SPE2DB25FFKWK

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a firm fixed price of $13,491.97 and a performance period through June 30, 2025. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, worth $12,560.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a medical product, with a completion date of June 25, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a Firm Fixed Price pricing type. This IDC, valued at $999,999,999, is a primary vehicle for...
This federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,559,458,471 units of the medication LUMAKRAS 120 MG TABLET 240S. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $23,687.42. The contract has an ultimate completion date of January 19, 2023 and was awarded on December 27, 2022. This award does not have...
This is a $13,491.97 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of June 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX to provide a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,994.89 firm fixed-price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $35,531.10 Firm Fixed Price Delivery Order provides for the delivery of the drug LUMAKRAS 120 MG TABLET 240S. The contract has an ultimate completion date of September 26, 2022 and was awarded on September 2, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FB5E6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,560.77 firm fixed-price delivery order is for the supply of 4564436669 ! LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency Troop Support Medical awarded a $12,042.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg tablets of LUMAKRAS in 240 count bottles. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were identified. This delivery order was issued on the agency's...
This federal contract award is a delivery order valued at $12,446.16, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKWK
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product. The contract has a ceiling value of $13,491.97 and runs through May 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:44 AM